🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

.Monica Guzman was involved with #ASH24 #research in collaboration with Williams Blood Cancer Research Group GCU Research Centre for Health (ReaCH) looking at how immune cells can cause therapy resistance in acute myeloid #leukemia (#AML): bit.ly/3ZvB9b0

Attention #BloodCancer trainees! Join an #ASH24 session featuring Monica Guzman discussing how to build and sustain a #research program: bit.ly/3ODUvFR

Interested on Building a Research Program ? Stop by to ask your pressing questions… sharing the stage with Dr. Allison King ! Clinical and basic/translational aspects will be covered!

One of my favorite things about ASH is the ability to connect with colleagues around the world that become friends as we build collaborations that eventually are presented! #ASH24 (pictures at the end was taken at #ASH22) Weill Cornell Leukemia Gail Roboz Nuria Mencia Trinchant Justin Kaner

Dr. Gail Roboz outlines results from an international #ClinicalTrial evaluating the efficacy of two standard therapies in acute myeloid #Leukemia (#AML) patients: bit.ly/3B3XODo #ASH24

Oral abstract DAC vs DA-90 in collaboration with Weill Cornell Leukemia and PALG presented by Agnieszka Wierzbowska. Excellent work that spanned several years and celebrated this evening at ASH! gail roboz Pinkal Desai Monica Guzman ashpublications.org/blood/article/… #ASH24

Left on Tenth on Broadway is a funny, romantic, heartfelt play based on a book written by Delia Ephron's own life story. It is a romantic comedy that also lets us see her battle against #AML under the care of Dr. Gail Roboz Weill Cornell Leukemia, Weill Cornell BMT Program, and with all the unconditional

Thanks NewYork-Presbyterian for a fun night on Broadway for Left on Tenth on Broadway. Wonderful to see our Weill Cornell Leukemia team highlighted esp Drs. Gail Roboz & Koen Van Besien. Thanks Delia Ephron for sharing your story! WCMHemOncFellow Joshua Fein Evelyn Orlando Molly Gilligan Leukemia Fighters

Proud moment at Broadway for the Weill Cornell Leukemia program as NewYork-Presbyterian sponsored a special performance of Left on Tenth !! NYP, WCM and Gail Roboz were featured in the play detailing Delia Ephron’s life and memoir on finding second chances… and her fight with leukemia.

Great to have Dr. Naveen Pemmaraju Naveen Pemmaraju, MD come visit Weill Department of Medicine Grands Rounds as our 2024 Richard T Silver Visiting Professor. Thanks for leading an engaging discussion at case conference with our WCMHemOncFellow!@CRTFund Weill Cornell Leukemia

Christine Garcia, MD, MPH Weill Department of Medicine WCMHemOncFellow Weill Cornell Leukemia Thank you 🙏Dr Christine Garcia, MD, MPH & thank you 🙏 WCMHemOncFellow & Cancer Research & Treatment Fund & Weill Cornell Leukemia Weill Cornell Medicine for graciously hosting me !! #MPNSM #leusm #BPDCN | #Leadership #meded

This year’s World Cancer Day theme is "United by Unique." Our collaborative approach to cancer care ensures patients receive top evaluations and therapies, including advancements in precision medicine and immune-based treatments. We make the fight against cancer personal.

Our #Leukemia team is dedicated to raising awareness for acute myeloid leukemia (#AML). On #AMLWorldAwarenessDay, we share our support and commitment to caring for patients and all those caregivers and loved ones impacted by this type of #BloodCancer. #KnowAML

Clinical research Weill Cornell Medicine NewYork-Presbyterian is dedicated to innovating, inspiring and transforming lives. On #ClinicalTrialsDay, some of our team members who support clinical research are sharing how we are Powered By Purpose. #CTD2025 ACRP - Assoc. of Clinical Research Profession

.Pinkal Desai is presenting on clonal hematopoiesis of indeterminate potential (CHIP) to acute myeloid #Leukemia (#AML) as part of an #ASCO25 education session this afternoon. Details here: bit.ly/4dDMj45

At #ASCO25, Pinkal Desai presented during a session on precursors to hematologic malignancies where she shared her expertise in CHIP, CCUS, cytopenias and the importance of risk stratification, with the ultimate goal of preventing disease progression

Dr. Gail Roboz shared details about potentially practice-changing #research evaluating an all-oral treatment regimen for acute myeloid #Leukemia presented at #ASCO25. Dr. Roboz will also be presenting this important study at #EHA2025 later this month bit.ly/4507IT4 #AML

Weill Cornell Leukemia Wrapping up #ASCO25 , honored to be part of a fantastic education session on Precursor to Hematologic Malignancies with Nadeem Omar and Jennifer Woyach . Weill Cornell Leukemia x.com/WCMLeukemia/st…

Happening at EHA , results of the ASCERTAIN-V of oral decitabine and venetoclax in AML presented by Gail Roboz . The study met its primary endpoint ! Weill Cornell Leukemia